• Follow Us
CDI Labs LogoCDI Labs Company Logo
  • LAB SERVICES
      • Service Platforms
      • OVERVIEW
      • HuProt™ Services
      • VirD™ Services
      • VirScan® Services*
      • HuScan® Services*
      • MouseScan™ Services*
      • Tech Access ProgramCustom PhIP-Seq Libraries*
      • Autoantibody Profiling Services
      • OVERVIEW
      • Biomarker Discovery
      • Patient Stratification
      • Patient Response / Adverse Reaction Prediction
      • Diagnostic Development
      • Vaccine Development and Safety
      • Viral Exposure Profiling
      • Target ID Services
      • OVERVIEW
      • Protein-Protein Interactions
      • Protein-Nucleic Acid Interactions
      • Target Deconvolution / Target Discovery
      • Antibody Specificity Validation
      • Post-translational Modification Specificity Testing
      • Chemically Induced Proximity (CIP)
      • Disease Areas
      • OVERVIEW
      • Autoimmune Disease
      • Oncology
      • Neurological Disease
      • Infectious Disease
      • Genetic Disease
      • * Provided exclusively by CDI Labs Canada.
  • SPECIALIZED CRO SERVICES
      • Specialized CRO Services
      • OVERVIEW
      • Antibody Development
      • Antibody Pairs
      • Protein Production
      • Cell Therapy Immunogenicity Testing
      • CRISPR-Cas9 Immunogenicity Testing
      • Post-translational Modification Specificity Profiling
      • Diagnostic Development
  • PROTEOMICS TECHNOLOGIES
      • HuProt™ MicroarrayContains 21,000+ Full-length Human Proteins
      • VirD™ Membrane ProteinContains429 Membrane Proteins and Isoforms
      • VirScan® PhIP-Seq*Detect antibodies against 68,000+ Viral Protein Sequences
      • HuScan® PhIP-Seq*Detect antibodies against 48,921 Human Proteins and Isoforms
      • MouseScan™ PhIP-Seq* Detect antibodies against 50,135 Murine Proteins and Isoforms
      • * Provided exclusively by CDI Labs Canada.
  • BIOINFORMATICS
      • Bioinformatics
      • OVERVIEW
  • RESOURCES
      • Resources
      • Library Content
      • Publications
      • Videos and Webinars
      • FAQs
  • NEWS  &  EVENTS
      • Blogs
      • Events
      • News
  • COMPANY
      • About Us
      • Leadership
      • Meet CDI Labs
      • Tech Access ProgramCustom PhIP-Seq Libraries*
      • Customer Testimonials
      • Contact Us
      • Sign-up for Our eNews
      • Privacy Policy
  • CONTACT US

You are now leaving the CDI Labs U.S. website and will be directed to the CDI Labs Canada website.

< Older Newer >
Download PDF
  • Share

Wednesday, Aug 02 2023

Barney E. Saunders Ph.D. has been appointed Chief Executive Officer of CDI Laboratories

MAYAGUEZ, Puerto Rico and BALTIMORE, Aug. 2, 2023 -- CDI Laboratories Inc., the Seromics™ company, announced today that Barney E. Saunders Ph.D. has been appointed Chief Executive Officer.


Dr. Saunders brings three decades in leadership positions commercializing and scaling life science tools and diagnostic businesses. Most recently, he was CEO of Purigen Biosystems where he, and the team, launched the Ionic® Purification System for preparing nucleic acid from clinical specimens and ultra-long DNA. From 2010 to 2017, Saunders led Sales & Marketing at NanoString Technologies, driving strong revenue growth that supported their IPO. As VP and GM at Agilent Technologies, he led the team that launched the first commercially-available full-genome arrays for human, rat, and mouse. Dr. Saunders began his career with Amersham International, a biopharma company acquired by General Electric in 2004. He holds a PhD in Molecular Biology from Birmingham University, England. 


Dr. Saunders commented on his appointment, “I am thrilled to join CDI’s team. They are pioneering the field of seromics, which with their HuProt and PhIP-Seq portfolio, provides a global view of an individual’s autoantibody immune repertoire from serum and other samples. I will be scaling CDI’s operations and commercial team to provide customers worldwide access to these transformational products for immune monitoring and drug trials”.


“Barney brings deep executive experience to life sciences and diagnostics, commercializing disruptive products and services,” said Dr. Ignacio Pino, co-founder and CDI’s initial CEO. “I look forward to working with him to continue driving CDI’s growth.”


Immuno-medicine is transforming the understanding and treatment of complex diseases. CDI is leading the field of ‘seromics’. It provides researchers with a global, proteome-scale view of an individual’s immune repertoire. CDI built its reputation on HuProt, the world’s most comprehensive human proteome array. HuProt is widely used for autoantibody seromics profiling, antibody-target identification, and other applications. CDI has recently become the first company to offer PhIP-Seq (next-generation phage-display immunoprecipitation sequencing), a whole-proteome, antigen-specific immune monitoring service, that further expands its seromics solutions.



Media Contact

Scott Paschke, VP

CDI Laboratories Inc.

+1 518-534-2881

[email protected]

  • CDI LABSLinkedin Feed
CDI Labs Footer LogoCDI Labs Company Footer Logo

Become part of the CDI Labs community

Sign up to receive emails on our latest news and updates.

Your First Name
Your Last Name
Your Work Email

Please enter ONLY your work email address.

Sign Up Submit Button

PLATFORMS

  • HuProt™ Proteome Microarray
  • VirD™ Membrane Protein Array
  • VirScan® Viral PhIP-Seq*
  • HuScan® Human PhIP-Seq*
  • MouseScan™ Murine PhIP-Seq*
  • * Provided exclusively by CDI Labs Canada.

SERVICES

  • HuProt™ Services
  • VirD™ Services
  • VirScan® Services*
  • HuScan® Services*
  • MouseScan™ Services*
  • Antibody Development
  • Autoantibody Profiling Overview
  • Target ID Overview
  • Disease Areas Overview
  • Specialized CRO Overview
  • Bioinformatics Overview
  • * Provided exclusively by CDI Labs Canada.

COMPANY

  • Resources
  • Library Content
  • Publications
  • FAQs
  • Videos and Webinars
  • Blogs
  • Events
  • News
  • Sign-up for Our eNews
  • About Us
  • Leadership

CONTACT

  • Email: [email protected]
  • Tel: +1 844-539-6296
  • CONTACT US
  • General Inquiries
  • [email protected]
  • Tel: +1 510 858-2855
  • Technical Support
  • [email protected]
  • Tel: +1 844 539-6296
  • Mailing Address
  • PO. Box 569
  • Mayagüez. PR 00681-0569
  • USA
  • CDI Labs - Mayagüez
  • 12 W Mendez Vigo Avenue
  • 2nd Floor
  • Mayagüez, PR 00680
  • USA
  • Tel: +1 939-280-5293
  • DIRECTIONS
  • CDI Labs - Baltimore
  • 1 N. Haven Street
  • Suite B001
  • Baltimore, MD 21224
  • USA
  • Tel: +1 844-539-6296
  • DIRECTIONS
  • CDI Labs Canada - Toronto
  • MaRS Centre - West Tower
  • 661 University Ave
  • Suite 1300
  • Toronto, ON
  • CANADA M5G 0B7
  • Tel: +1 647-243-5289
  • DIRECTIONS
  • Follow Us

FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.

© 2025 CDI Labs. All rights reserved.

  • Privacy Policy
  • |
  • Cookie Policy
  • |
  • Terms of Use - Web
  • |
  • Terms & Conditions - Sales
  • |
  • Terms & Conditions - Services